103 related articles for article (PubMed ID: 28439829)
1. Cell-Free Urinary MicroRNAs Expression in Small-Scale Experiments.
Zavesky L; Jandakova E; Turyna R; Duskova D; Langmeierova L; Weinberger V; Minar L; Horinek A; Kohoutova M
Methods Mol Biol; 2017; 1580():99-106. PubMed ID: 28439829
[TBL] [Abstract][Full Text] [Related]
2. Supernatant versus exosomal urinary microRNAs. Two fractions with different outcomes in gynaecological cancers.
Zavesky L; Jandakova E; Turyna R; Langmeierova L; Weinberger V; Minar L
Neoplasma; 2016; 63(1):121-32. PubMed ID: 26639242
[TBL] [Abstract][Full Text] [Related]
3. Evaluation of Cell-Free Urine microRNAs Expression for the Use in Diagnosis of Ovarian and Endometrial Cancers. A Pilot Study.
Záveský L; Jandáková E; Turyna R; Langmeierová L; Weinberger V; Záveská Drábková L; Hůlková M; Hořínek A; Dušková D; Feyereisl J; Minář L; Kohoutová M
Pathol Oncol Res; 2015 Sep; 21(4):1027-35. PubMed ID: 25827090
[TBL] [Abstract][Full Text] [Related]
4. Discovery and Evaluation of Extracellular MicroRNA Biomarkers in Plasma, Ascites, and Urine.
Záveský L; Slanař O
Methods Mol Biol; 2023; 2630():135-143. PubMed ID: 36689181
[TBL] [Abstract][Full Text] [Related]
5. A Robust Protocol to Quantify Circulating Cancer Biomarker MicroRNAs.
Bell E; Watson HL; Bailey S; Murray MJ; Coleman N
Methods Mol Biol; 2017; 1580():265-279. PubMed ID: 28439839
[TBL] [Abstract][Full Text] [Related]
6. Comparison of commercial exosome isolation kits for circulating exosomal microRNA profiling.
Ding M; Wang C; Lu X; Zhang C; Zhou Z; Chen X; Zhang CY; Zen K; Zhang C
Anal Bioanal Chem; 2018 Jun; 410(16):3805-3814. PubMed ID: 29671027
[TBL] [Abstract][Full Text] [Related]
7. Diagnostic and prognostic significance of miRNA signatures in tissues and plasma of endometrioid endometrial carcinoma patients.
Torres A; Torres K; Pesci A; Ceccaroni M; Paszkowski T; Cassandrini P; Zamboni G; Maciejewski R
Int J Cancer; 2013 Apr; 132(7):1633-45. PubMed ID: 22987275
[TBL] [Abstract][Full Text] [Related]
8. Mutually distinguishing microRNA signatures of breast, ovarian and endometrial cancers in vitro.
Hirschfeld M; Ge I; Rücker G; Waldschmidt J; Mayer S; Jäger M; Voigt M; Kammerer B; Nöthling C; Berner K; Weiss D; Asberger J; Erbes T
Mol Med Rep; 2020 Nov; 22(5):4048-4060. PubMed ID: 33000259
[TBL] [Abstract][Full Text] [Related]
9. Variability in microRNA recovery from plasma: Comparison of five commercial kits.
Brunet-Vega A; Pericay C; Quílez ME; Ramírez-Lázaro MJ; Calvet X; Lario S
Anal Biochem; 2015 Nov; 488():28-35. PubMed ID: 26271186
[TBL] [Abstract][Full Text] [Related]
10. miR-941 as a promising biomarker for acute coronary syndrome.
Bai R; Yang Q; Xi R; Li L; Shi D; Chen K
BMC Cardiovasc Disord; 2017 Aug; 17(1):227. PubMed ID: 28830367
[TBL] [Abstract][Full Text] [Related]
11. Peripheral leukocyte microRNAs as novel biomarkers for COPD.
Wang R; Xu J; Liu H; Zhao Z
Int J Chron Obstruct Pulmon Dis; 2017; 12():1101-1112. PubMed ID: 28435243
[TBL] [Abstract][Full Text] [Related]
12. Feasibility of urinary microRNA profiling detection in intrahepatic cholestasis of pregnancy and its potential as a non-invasive biomarker.
Ma L; Zhang XQ; Zhou DX; Cui Y; Deng LL; Yang T; Shao Y; Ding M
Sci Rep; 2016 Aug; 6():31535. PubMed ID: 27534581
[TBL] [Abstract][Full Text] [Related]
13. Plasma miRNAs in predicting radiosensitivity in non-small cell lung cancer.
Chen X; Xu Y; Liao X; Liao R; Zhang L; Niu K; Li T; Li D; Chen Z; Duan Y; Sun J
Tumour Biol; 2016 Sep; 37(9):11927-11936. PubMed ID: 27075472
[TBL] [Abstract][Full Text] [Related]
14. Comparative microRNA profiling in relation to urinary albumin excretion in newly diagnosed hypertensive patients.
Parthenakis FI; Marketou ME; Kontaraki JE; Maragoudakis F; Maragkoudakis S; Nakou H; Roufas K; Patrianakos A; Chlouverakis G; Malliaraki N; Vardas PE
J Hum Hypertens; 2016 Nov; 30(11):685-689. PubMed ID: 26984682
[TBL] [Abstract][Full Text] [Related]
15. Distinctive expression signatures of serum microRNAs in ischaemic stroke and transient ischaemic attack patients.
Wu J; Fan CL; Ma LJ; Liu T; Wang C; Song JX; Lv QS; Pan H; Zhang CN; Wang JJ
Thromb Haemost; 2017 May; 117(5):992-1001. PubMed ID: 28251236
[TBL] [Abstract][Full Text] [Related]
16. A restricted signature of serum miRNAs distinguishes glioblastoma from lower grade gliomas.
Regazzo G; Terrenato I; Spagnuolo M; Carosi M; Cognetti G; Cicchillitti L; Sperati F; Villani V; Carapella C; Piaggio G; Pelosi A; Rizzo MG
J Exp Clin Cancer Res; 2016 Jul; 35(1):124. PubMed ID: 27476114
[TBL] [Abstract][Full Text] [Related]
17. Potential of mid-infrared spectroscopy as a non-invasive diagnostic test in urine for endometrial or ovarian cancer.
Paraskevaidi M; Morais CLM; Lima KMG; Ashton KM; Stringfellow HF; Martin-Hirsch PL; Martin FL
Analyst; 2018 Jun; 143(13):3156-3163. PubMed ID: 29878018
[TBL] [Abstract][Full Text] [Related]
18. Quantification of Circulating MicroRNAs by Droplet Digital PCR.
Ferracin M; Negrini M
Methods Mol Biol; 2018; 1768():445-457. PubMed ID: 29717458
[TBL] [Abstract][Full Text] [Related]
19. Differential expression levels of plasma microRNA in Hashimoto's disease.
Zhao L; Zhou X; Shan X; Qi LW; Wang T; Zhu J; Zhu D; Huang Z; Zhang L; Zhang H; Yin Y; Wang Z; Zhu W; Cheng W; Jiang L
Gene; 2018 Feb; 642():152-158. PubMed ID: 29054761
[TBL] [Abstract][Full Text] [Related]
20. MicroRNA profiling in ovarian cancer.
Iorio MV; Croce CM
Methods Mol Biol; 2013; 1049():187-97. PubMed ID: 23913217
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
